GENEVA, Oct. 5 -- SILICOPHARM, INC. filed a patent application (KR2025/004138) for “PHARMACEUTICAL COMPOSITION FOR COMBINED ADMINISTRATION FOR PREVENTING OR TREATING CANCER, COMPRISING ISA-2011B AND ERLOTINIB”. With publication no. WO/2026/205621, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4985
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....